Fosphenytoin
Back to searchMolecule Structure
Scientific Name
Fosphenytoin
Description of the Drug
Fosphenytoin is an antiepileptic agent used for the management of generalized convulsive status epilepticus and prevention and treatment of seizures occurring during neurosurgery.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01320
http://www.drugbank.ca/drugs/DB01320
Brand Name(s)
Not Available
Company Owner(s)
Parke Davis Div Warner Lambert Co, Apotex Inc, Fresenius Kabi Usa Llc, Mylan Laboratories Ltd, Lupin Inc, Hospira Inc, Sun Pharmaceutical Industries Ltd, Hikma Farmaceutica (Portugal) Sa, American Regent Inc, Dr Reddys Laboratories Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL94254 | ||
| PharmGKB | PA164746820 | ||
| Human Metabolome Database | HMDB0015417 | ||
| DrugBank | DB01320 | ||
| PubChem: Thomson Pharma | 14779124 | ||
| PubChem | 56339 | ||
| Nikkaji | J540.502E | ||
| EPA CompTox Dashboard | DTXSID9044299 | ||
| DrugCentral | 1247 | ||
| Guide to Pharmacology | 7190 | ||
| rxnorm | FOSPHENYTOIN SODIUM | CEREBYX | FOSPHENYTOIN |
| KEGG Ligand | C07840 | ||
| ChEBI | 5165 | ||
| ZINC | ZINC000001530922 |
